- Home
- ORGO vs ANPA Comparison
ORGO vs ANPA Comparison
Compare ORGO & ANPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ANPA
- Stock Information
- Founded
- ORGO 1985
- ANPA 2016
- Country
- ORGO United States
- ANPA Hong Kong
- Employees
- ORGO N/A
- ANPA N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ANPA
- Sector
- ORGO Health Care
- ANPA
- Exchange
- ORGO Nasdaq
- ANPA Nasdaq
- Market Cap
- ORGO 620.3M
- ANPA 509.0M
- IPO Year
- ORGO N/A
- ANPA 2025
- Fundamental
- Price
- ORGO $4.08
- ANPA $27.45
- Analyst Decision
- ORGO Buy
- ANPA
- Analyst Count
- ORGO 3
- ANPA 0
- Target Price
- ORGO $7.33
- ANPA N/A
- AVG Volume (30 Days)
- ORGO 800.7K
- ANPA 49.4K
- Earning Date
- ORGO 11-06-2025
- ANPA 01-01-0001
- Dividend Yield
- ORGO N/A
- ANPA N/A
- EPS Growth
- ORGO N/A
- ANPA N/A
- EPS
- ORGO N/A
- ANPA 0.06
- Revenue
- ORGO $429,531,000.00
- ANPA $5,832,684.00
- Revenue This Year
- ORGO $2.51
- ANPA N/A
- Revenue Next Year
- ORGO $25.45
- ANPA N/A
- P/E Ratio
- ORGO N/A
- ANPA $470.75
- Revenue Growth
- ORGO N/A
- ANPA N/A
- 52 Week Low
- ORGO $2.61
- ANPA $2.80
- 52 Week High
- ORGO $6.71
- ANPA $54.75
- Technical
- Relative Strength Index (RSI)
- ORGO 37.32
- ANPA N/A
- Support Level
- ORGO $4.12
- ANPA N/A
- Resistance Level
- ORGO $4.40
- ANPA N/A
- Average True Range (ATR)
- ORGO 0.24
- ANPA 0.00
- MACD
- ORGO -0.06
- ANPA 0.00
- Stochastic Oscillator
- ORGO 11.96
- ANPA 0.00
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ANPA Rich Sparkle Holdings Limited Ordinary Shares
Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.